FORMULATION AND ASSESSMENT OF LIPOSOMAL DELIVERY SYSTEMS FOR TARGETED HEPATOPROTECTIVE DRUG DELIVERY TO THE LIVER
Main Article Content
Keywords
Lipid Microspheres, Silymarin, Soya Lecithin
Abstract
This study investigates the development of silymarin-loaded lipid microspheres aimed at enhancing the hepatic delivery and bioavailability of silymarin, a known hepatoprotective agent. Liposomes, niosomes, and lipid emulsions were considered as potential carriers, with lipid emulsions selected due to their favorable properties. Soybean lecithin and Tween 80 were used as surfactants, with soybean oil as the lipid phase. The formulations were characterized in terms of drug release, size distribution, stability, and drug-holding capacity. The silymarin lipid emulsion (Formulation A) exhibited significantly higher drug release compared to a silymarin solution (Formulation B), demonstrating superior stability and drug retention. Transmission electron microscopy (TEM) confirmed the near-spherical shape of the microspheres, with a size range of 0.31–1.24 µm. The drug release from Formulation A was enhanced, indicating its potential for targeted liver delivery with minimized drug loss during transit.
References
2. Jaeschke, H., Werner, C., and Wendel, A. Disposition and Hepatoprotec- tion by phosphatidyl Choline liposomes in mouse liver. Chem. Biol. Interact. 64: 1987; 127–137.
3. Karison, P. Kurzes Lehrbuch der Biochemic fu¨r Mediziner and Naturwis- senschaftler. Thieme Verlag. 1984; 134–141.
4. Miguez, M. P., Anundi, I., Sainz-Pardo, L. A., and Lindros, K. O. Hepatoprotective mechanism of Silymarin: No evidence for involvement of Cytochrome P450 2E1. Chem. Biol. Interact. 91: 1994; 51–63.
5. Miyata, I., Miyamoto, H., and Yonese, M. Effect of chain lengths of n-Alcohol on the formation of Single-phase microemulsions in n-Heptane/n-Alcohol/sodium Dodecyl Sulfate/water systems. Chem. Pharm. Bull. 1996; 1049–1055.
6. Mizushima, Y., Hamano, T., and Yokoyama, K. Use of lipid emulsions as a novel carrier for consticosteroids. J. Pharm. Pharmacol. 34: 1982; 49–50.
7. Mizushima, Y., Wada, Y., Etoh, Y., and Watanabe, K. Antiinflammatory effect of indomethacin ester incorporated in lipid microsphere. J. Pharm. Pharmacol. 35: 1983; 398–399.
8. Moreno, M. A., Frutos, P., and Ballesteros, M. P. Lyophilized lecithin based oil-in-water microemulsions as new and low toxic delivery system for Amphotericin B. Pharm. Res. 18: 2001; 344–351.
9. Wellington, K., and Jarvis, B. Silymarin: A review of its clinical properties in the management of hepatic disorders. Bio. Drugs. 15: 2001; 465–489.
10. Yamaguchi, T. Lipid microspheres for drug delivery from the pharmaceu- tical viewpoint. Crit. Rev. Ther. Drug Carrier Sys. 11: 1994; 215–229